Pain management related intravenous cannulation.
Conditions
Interventions
Intervention group: In the beginning, the patient’s consent is taken, and then a lottery is made to choose the intervention, either Shotblocker or ShotBlocker placebo, then a fill questionnaire, and t
Sponsors
College of Nursing, University of Baghdad
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Consent to volunteer to participate in the study. Being between the ages of 6 and 12 years. Intravenous cannulation will be applied in right and left hand only. No difficulty in communication, including hearing, visual, speech, and language problems. Not receiving oral or parenteral analgesic treatment before administration. Not receiving chemotherapy treatment.
Exclusion criteria
Exclusion criteria: Skin conditions such as burns, rashes, open wounds, abscess or boil, severe local infection or cellulitis at the intended insertion site. Peripheral vascular disease or compromised peripheral circulation at the intended insertion site (e. g. Peripheral neuropathy, diabetes, Peripheral artery disease, Raynaud's disease). Blood clotting disorders or increased risk of bleeding (e.g., hemophilia, thrombocytopenia). Anatomical abnormalities or restrictions that impede proper insertion or cause increased risk of complications. History of injections during the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intravenous cannulation related pain (reducing). Timepoint: The patient's response after giving the intravenous cannulation directly to measure the intensity of pain. Method of measurement: Pain scale (Wong-Baker Faces) to measure the intensity of pain as a result of intravenous cannulation. | — |
Countries
Iraq
Contacts
Public ContactSalsabeel Alaa Nasser
University of Baghdad,College of Nursing
Outcome results
None listed